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Abstract 
To evaluate the apoptosis involvement in the
angiogenesis  as  a  self-limiting  process  in
patients with temporomandibular joint (TMJ)
degenerated  disc  vessels,  we  assessed,  by
immunohistochemistry,  the  detection  of
TRAIL, its death receptor DR5 and caspase 3.
TRAIL, its death receptor DR5 and caspase 3
expression  were  studied  by  immunohisto-
chemistry in 15 TMJ discs displaced without
reduction  and  in  4  unaffected  discs.  These
apoptosis molecules were detected in the inti-
ma and media layers of newly formed vessels
affected discs. In conclusion, vessels apoptosis
activation in TMJ disc with ID could be regard-
ed as a self-limiting process that try to leads to
vessel regression; in this way an inhibition of
angiogenic vessels may prove a key strategy in
limiting pathological angiogenesis, by cutting
off  blood  supply  to  tumors,  or  by  reducing
harmful inflammation.
Introduction
The formation of new blood vessels is an
essential part of many physiological and patho-
logical  processes  including  embryogenesis,
wound healing, formation of blood supply to
tumors or ischemic tissue and as a driver of
inflammatory diseases.
1-3
Adult  human  temporomandibular  joint
(TMJ) disc is devoid of blood vessels, except
for the bilaminar zone.
4,5 The absence of a vas-
cular supply and the compact arrangement of
the fibrous component are considered to be the
morphological  characteristics  that  allow  the
human  TMJ  disc  to  bear  the  compression
forces of articulation.
6 In contrast, a high den-
sity  of  blood  vessels  is  described  in  discs
affected by internal derangement (ID) of the
joint.
7-9
ID involves an altered anatomical relation-
ship of the disc-condyle complex and it is like-
ly to lead to histopathological changes that cul-
minate  in  tissue  degeneration  as  occurs  in
disc displacement TMJ discs.
10-17 Very little lit-
erature data concerning the distribution of the
newly differentiated capillaries in TMJ ID discs
exists.  Since  blood  capillaries  increase  in
number with the degree of inflammation dur-
ing tissue repair, previous authors have evalu-
ated CD34 immunoreactivity not only in the
walls  of  blood  capillaries  within  internal
derangement TMJ disc, but also in the posteri-
or loose connective tissue of bilaminar zone.
CD34  is  a  human  cell  antigen  usually
expressed by hematopoietic bone marrow pro-
genitor cells and it is used as a sensitive mark-
er of vascular endothelium. The previous find-
ings  showed  that  CD34  immunostaining
appear  to  be  correlated  with  the  severity  of
TMJ ID.
18 It has also been demonstrated that in
inflammatory,  degenerative  and  hypoxial
states  and/or  mechanical  stress,  several
cytokines as interleukin 1 β (IL-1β), prosta  -
glandin E (PGE), epidermal growth factor β1
(EGFR-β1), and tumor necrosis factor α (TNF-
α)  could  activate  the  vascular  endothelium
and initiate angiogenesis inducing the expres-
sion of a cytokine called vascular endothelial
growth  factor  (VEGF).
19-22 Some  authors
demonstrated that VEGF was also expressed by
chondrocyte-like cells of perforated TMJ discs,
showing a similar distribution with chondro-
modulin-1  (ChM1)  glycoprotein,  postulating
that the existence of ChM-1 could neutralize
the angiogenic effect of VEGF preventing, in
this  way,  blood  vessel  invasion  at  the
arthropatic site.
In hypertrophic cartilage VEGF seems to be
released by chondrocytes in a paracrine way,
using endothelial cells as a target
23 and that it
is essential to correct directional growth and
cartilage invasion by blood vessels. Moreover,
it has been argued that during an inflammato-
ry process, VEGF could contribute, by chemo-
taxis of macrophage and promoting angiogen-
esis, to the activation of cellular pathways that
induce apoptosis in such proliferative regions. 
Apoptosis, or programmed cell death, is an
integral  part  of  development  as  seen  in
embryogenesis, normal tissue turnover, cellu-
lar  homeostasis  and  a  variety  of  diseases
resulting from its dysregulation.
24
Apoptosis processes involve a Fas or tumor
necrosis  factor  (TNF)-α associated  extrinsic
pathway  and  a  mitochondrial  associated
intrinsic pathway. In particular, tumor necrosis
factor-related apoptosis-inducing ligand (TRAIL)
Apo-2L is a type II membrane protein, which
can be proteolytically cleaved by cysteine pro-
teases to a soluble form,
25 as also shown for
TNF- α and CD95 (Apo-1/Fas) ligand. When
TRAIL binds a death receptor, the death induc-
ing signalling complex assembles at the death
receptor domain, resulting in caspase 8 activa-
tion that causes direct cleavage of caspase 3
into active subunits that execute apoptosis.
26
Notably, the vessel wall is a rich source of cys-
teine  proteases,
27 which  suggests  that
TRAIL/TRAIL-R systems probably play a physio-
logical role in vascular biology.
Hence in this paper, we examined, through
immunohistochemistry,  the  detection  of
TRAIL, its death receptor DR5 and caspase 3 in
TMJ degenerated disc vessels in order to eval-
uate the apoptosis involvement in angiogene-
sis as a self-limiting process. 
Materials and Methods
Patients and tissues
Specimens  were  15  displaced  TMJ  discs
from  the  archives  of  the  Pontifical  Catholic
University  of  Paraná,  Curitiba,  Brazil.  The
study was approved by the local ethics commit-
tee. The informed consent of each patient was
obtained before disc removal. Discs came from
12 women and 3 men with TMJ ID. All had
anterior disc displacement without reduction
(ADDwoR),  as  confirmed  by  clinical  history,
physical examination and magnetic resonance
imaging (MRI). Their mean age at the time of
surgery was 37.2 years (±4.4); the mean inter-
val from ID symptom onset to surgery was 7.9
months (±0.6). Unassisted maximum mouth
opening (MMO), determined with a millimeter
ruler as interincisal distance, and a visual ana-
log scale (VAS), to measure pain intensity in
the preceding week, were used to assess dis-
ease severity. The VAS anchor points were 0
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for “no pain” and 100 for “the worst imagina-
ble pain.” These data are reported in Table 1.
The diagnosis that led to surgery was TMJ
ID  with  pain  and  functional  impairment.
Inclusion criteria were: i) unsuccessful non-
surgical treatment; ii) TMJ tenderness to pal-
pation; and iii) TMJ pain or interference with
mandibular  movements.  Exclusion  criteria
were:  i)  other  TMJ  diseases;  ii)  dentofacial
deformity; ii) major jaw trauma; iv) previous
TMJ  surgery;  and  v)  previous  TMJ  steroid
injections. After removal, all discs were seen to
be macroscopically deformed, none having a
normal biconcave shape. 
Discectomy  has  come  under  increasing
attack  as  the  standard  therapy  for  disc  dis-
placement,  with  a  number  of  surgeons  now
favoring  a  conservative  approach  and  other
researchers still believing in its value.
28-30 Disc
removal  is  therefore  ethically  justified.  This
small sample of whole TMJ discs was investi-
gated because they provide exhaustive infor-
mation on the characteristics of tissue degen-
eration.
Four virtually unaffected human TMJ discs
from the collection of the Anatomy Institute of
Catania University, Catania, Italy, were studied
for  comparison.  These  paraffin-embedded
autopsy specimens from one male and three
female  subjects  (mean  age  49.7±4.4  years)
were selected because the donors’ clinical his-
tories were negative for generalized joint dis-
ease  or  TMJ  arthropathy.  On  dissection  the
discs showed no macroscopic signs of degener-
ative or inflammatory joint disease or displace-
ment. They were stained with Harry’s hema-
toxylin and exhibited no detectable pathologi-
cal changes on light microscopy. 
Immunohistochemistry
For the immunohistochemical staining the
discs  were  fixed  overnight  in  10%  neutral
buffered  formalin  (Bio-Optica,  Milan,  Italy).
After  fixation  and  overnight  washing,  each
disc was sectioned through its center along a
parasagittal  plane,  perpendicular  to  its  long
axis. Each tissue block was dehydrated in grad-
ed ethanol, and embedded in paraffin preserv-
ing  the  longitudinal  anatomical  orientation.
Specimens were sectioned at a thickness of 5
µm and placed on silanized glass slides (the
anterior band being always on the right side of
the  slides).  Endogenous  peroxidase  activity
was quenched by treatment with 3% H2O2 for
10 min. Non-specific binding of antibodies was
blocked by normal horse/goat serum treatment
[diluted  1:20  in  phosphate  buffered  saline
(PBS),  0.1%  bovine  serum  albumin  (BSA)].
The  sections  were  irradiated  (5  min¥3)  in
capped polypropylene slide-holders with citrate
buffer (pH 6), using a microwave oven (750 W)
to unmask antigenic sites. 
A rabbit polyclonal anti-caspase 3 antibody
(Cell Signaling Technology, Inc., Denver, MA,
USA),  a  rabbit  polyclonal  anti-TRAIL  (Santa
Cruz Biotecnology, Inc., CA, USA) and a rabbit
polyclonal  anti-DR5  (Novus  Biologicals,  Inc.,
Littleton, USA) used respectively at 1:100, 1:20
and 1:20 working dilution (in PBS, 0.1% BSA),
were applied on each section and incubated
overnight  at  +4°C  in  a  moist  chamber.
Immunocomplexes  were  detected  by  incuba-
tion with the secondary antibody and then with
streptavidin-peroxidase complexes for 15 mins
each  at  room  temperature  (LSAB2/HRP  kit,
DAKO, Denmark). After rinsing in 3 changes
of PBS, the immunoreaction was visualized by
incubating sections in a 0.1% 3.3'-diaminoben-
zidine and 0.02% hydrogen peroxide solution
(DAB substrate kit, Vector Lab., Burlingame,
CA, USA) for 4 min. The sections were lightly
counterstained  with  Mayer’s  haematoxylin
(Histolab Products AB, Goteborg, Sweden) and
finally  mounted  on  GVA  mount  (Zymed
Laboratories Inc., San Francisco, CA, USA). 
Evaluation of immunohistochemistry
TRAIL, DR5 and caspase 3 stain intensity
and  the  proportion  of  immunopositive  cells
were  examined,  blinded  by  light  microscopy
and recorded. Intensity of staining (IS) was
graded on a scale range from 0 to 4, according
to the following semiquantitative assessment:
0=no  detectable  staining,  1=weak  staining,
2=moderate  staining,  3=strong  staining,
4=very  strong  staining.  The  percentage  of
TRAIL,  DR5  and  caspase  3  immunopositive
cells (extent score=ES) was also independent-
ly evaluated and scored as a percentage of the
final number of 200 cells in four categories:
0≤5%;  1=6-30%;  2=31-50%;  3≥50%,  and
4≥75%. Counting was performed at X 200 mag-
nification. The final staining score (FSS) was
derived from the sum of the intensity score
added to the extent score. 
Positive and negative control
This was performed to test the specific reac-
tion of the primary antibody at protein level.
For positive control testing basal cell carci-
noma tissue was exposed to an immunoperox-
idase process. For negative controls, randomly
selected TMJ disc sections were treated with
normal  rabbit  serum  instead  of  the  specific
antibody.
Statistical analysis
Data  were  analyzed  using  the  Mann-
Whitney U-tests; P<0.05 were considered sig-
nificant.  Mean  and  standard  deviation  were
calculated for both the FSS and HDS. All data
were analyzed with the SPSS program (SPSS®
release 16.0, Chicago, IL, USA). 
Results
All  TMJ  patients  had  been  unsuccessfully
treated with other various interventions for at
least 8 months prior to surgery. The control
discs showed preservation of multidirectional
collagen bundles, predominately fibrocyte-like
cell  populations  with  few  chondrocytes-like
cells aggregates, and absence of clefts or fray-
ing and vascular vessels. In contrast diseased
disc  sections,  stained  with  hematoxylin
showed a different degree of morphologic dam-
age, ranging from an altered collagen bundle
structure to fragmention and the presence of
newly formed vessels. A high immunoexpres-
sion of TRAIL (Figure 1 A, B), its receptor DR5
(Figure 2 A, B) and caspase 3 (Figure 3 A, B)
was demonstrated in the intima and media lay-
ers of newly formed vessels where cells were
strongly positive (IS score=3). The mean FSS
of all samples was 4.60±0.54 (range 3.4-5.8). 
Immunohistochemical  reactivity  for  TRAIL
and caspase-3 was detected in cells cytoplasm,
and the immunoexpression of DR5 was recog-
nized in cell membrane and cytoplasm. 
Discussion
TMJ  ID  is  often  accompanied  by  chronic
inflammatory  changes  including  growth  of
small new vessels.
31-34 It would seem that these
degenerative changes, as in other joints, are
influenced by the kind (anterior disc displace-
ment  with  or  without  reduction)  and  the
degree  of  disc  displacement.  Our  study  evi-
denced a high immunoexpression of TRAIL, its
receptor DR5 and caspase 3 in the intima and
media  layers  of  newly  formed  vessels  that
reflects an activation of the apoptosis mecha-
nism in these structures. Apoptosis process is
Original paper
Table  1.  Clinical  characteristics  of  patients  with  anterior  disc  displacement  without
reduction.
Patients’ age Unassisted  Visual analog scale
mouth opening maximum
MV SD MV SD MV SD
ADDwoR 34.4 4.2 27.4 4.6 83 6
MV, mean value; SD, standard deviation.[European Journal of Histochemistry 2010; 54:e40] [page 177]
in  fact  activated  by  the  extrinsic  pathway,
through TRAIL which cross-linking DR4 and
DR5 receptors death on the surface of target
cells particularly in microvascular endothelium
as mechanism of defence. 
Some authors have just tried to understand
how the process of formation of new vessels,
including endothelial proliferation, migration
and tube formation, is limited through induc-
tion of endothelial apoptosis, which leads to
vessel regression. However, literature reports
on the pro-angiogenetic or anti-angiogenetic
action of TRAIL, in in vitro studies, showed
contrasting  results.  Some  authors  evidenced
the stimulatory effect of TRAIL on cell endothe-
lial proliferation and its inducing activation of
Akt and Erk that leads to endothelial prolifera-
tion, increased cell migration and tube forma-
tion without altering endogenous endothelial
expression  of  VEGF
35,36 while  others,  on  the
contrary, demonstrated that TRAIL was found
to  inhibit  tube  formation,  cell  numbers  and
endogenous  VEGF  expression.
37 Probably  the
anti-angiogenic action of TRAIL is induced by
higher  doses  of  this  ligand.
38 Actually,  the
growth of microvessels by VEGF acts through
Akt pathway and can be blocked when Akt is
inhibited  by  various  anti-angiogenic  factors
namely angiotensin II and thromboxane A2.
39,40
The ability of TRAIL to activate the antiapop-
totic PI3k/Akt pathway in endothelial cells is
also an unexpected finding.
41 A possible expla-
nation is that the PI3k/Akt impairs the activa-
tion of the apical caspases by inhibiting the
recruitment  of  procaspase-8  to  the  death-
inducing  signalling  complex.
42 Really,  as  for
others morphological features just observed in
TMJ diseases, only restricted and focal areas of
new vascular profiles have been revealed. 
Thus, our present study sustains the hypoth-
esis that angiogenesis reports in degenerative
disc tissue are maintained localized thanks to
the apoptotic process. In particular, we demon-
strated  both  an  activation  of  the  process
through the receptor pathway and the progres-
sion of cell death through the activation of the
executioner caspase 3 that, in turn, leads to
cytoskeletal  proteins  degradation  and  DNA
fragmentation. It is suggested that TRAIL selec-
tively  binds  death  receptor  DR5  endothelial
cells in a dose dependent manner and enhance
apoptosis by caspase 8 and caspase 3 pathway.
Our previous study on TMJ disc ID demonstrat-
ed that TRAIL was overexpressed in apoptotic
chondrocyte like cells,
43,44 tissue apoptotic cell
death seems to be responsible for disc tissue
degeneration being correlated with the severi-
ty of disc pathologic findings.
45-47 For patients
with complete TMJ meniscus dislocation with
internal  derangement,  some  indications  that
this  tissue  is  undergoing  adaptive  changes
include the presence of thickened arterial walls
suggesting a decreased blood flow.
48
In conclusion, this study allows to hypothe-
size that angiogenesis is maintained localized
thanks to the apoptotic process in degenera-
tive disc tissues, thus vessel apoptosis activa-
tion in TMJ disc with ID could be regarded as a
self-limiting process that tries to lead to vessel
regression. In this way an inhibition of angio-
genic vessels may prove to be a key strategy in
limiting pathological angiogenesis, by cutting
off the blood supply to tumors or by reducing
harmful inflammation. 
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